Kindly MD grants stock options to execs, raises $4.2M from warrant exercises

Nakamoto Inc.

CEO Pickett gets 7,479 options vesting Sep 1, 2025, plus 28,780 restricted shares fully vested.
CFO Barrera gets 35,000 options vesting over 9 months; COO Cox gets 40,000 options with same vesting.
Independent directors each receive 1,838 restricted shares, 538 fully vested options, 2,000 change-of-control options.
All three execs waive future equity rights in Kindly MD and Nakamoto Holdings; waive good reason claims tied to merger.
Since May 12, 730,923 shares issued on warrant exercises, netting $4,219,584 through May 15.

item 5.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001641172-25-011283
form_type: 8-K
ticker: NAKA
cik: 0001946573
company_name: Nakamoto Inc.
filed_at: 2025-05-16T23:59:59+00:00
discovered_at: 2026-05-14T18:02:50.536682+00:00
generated_at: 2026-05-21T03:43:55.941086+00:00
sec_items: ["5.02", "8.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001641172-25-011283
json_url: https://secwatch.observer/filing/0001641172-25-011283.json
markdown_url: https://secwatch.observer/filing/0001641172-25-011283.md
text_url: https://secwatch.observer/filing/0001641172-25-011283.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1946573/000164117225011283/0001641172-25-011283-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1946573/000164117225011283/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001641172-25-011283

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.